These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 10733595)
1. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595 [TBL] [Abstract][Full Text] [Related]
2. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B. Frost SJ; Simpson DJ; Farrell WE Mol Cell Endocrinol; 2001 May; 176(1-2):29-37. PubMed ID: 11369440 [TBL] [Abstract][Full Text] [Related]
3. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462 [TBL] [Abstract][Full Text] [Related]
4. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P; Schmidt M; Hu X; Wolff L Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863 [TBL] [Abstract][Full Text] [Related]
5. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma. Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774 [TBL] [Abstract][Full Text] [Related]
6. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362 [TBL] [Abstract][Full Text] [Related]
7. Rb independent inhibition of cell growth by p15(INK4B). Aytac U; Konishi T; David H; Mendoza S; Miller CW Biochem Biophys Res Commun; 1999 Aug; 262(2):534-8. PubMed ID: 10462509 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer. Qian X; Durkin ME; Wang D; Tripathi BK; Olson L; Yang XY; Vass WC; Popescu NC; Lowy DR Cancer Res; 2012 Nov; 72(22):5900-11. PubMed ID: 23010077 [TBL] [Abstract][Full Text] [Related]
9. Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis. Xia Y; Liu Y; Yang C; Simeone DM; Sun TT; DeGraff DJ; Tang MS; Zhang Y; Wu XR Nat Commun; 2021 Apr; 12(1):2047. PubMed ID: 33824349 [TBL] [Abstract][Full Text] [Related]
10. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation. Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. Rich JN; Zhang M; Datto MB; Bigner DD; Wang XF J Biol Chem; 1999 Dec; 274(49):35053-8. PubMed ID: 10574984 [TBL] [Abstract][Full Text] [Related]
12. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas. Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056 [TBL] [Abstract][Full Text] [Related]
14. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227 [TBL] [Abstract][Full Text] [Related]
15. Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16(INK4a) and p15(INK4b) cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells. Muscarella P; Knobloch TJ; Ulrich AB; Casto BC; Moniaux N; Wittel UA; Melvin WS; Pour PM; Song H; Gold B; Batra SK; Weghorst CM Gene; 2001 Oct; 278(1-2):235-43. PubMed ID: 11707341 [TBL] [Abstract][Full Text] [Related]
16. p16 is a major inactivation target in hepatocellular carcinoma. Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001 [TBL] [Abstract][Full Text] [Related]
17. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2. Wen-Sheng W Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661 [TBL] [Abstract][Full Text] [Related]
20. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation. Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]